Patidegib Topical Gel, 2% + Patidegib Topical Gel, Vehicle
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Basal Cell Nevus Syndrome
Conditions
Basal Cell Nevus Syndrome
Trial Timeline
Feb 19, 2019 → Dec 28, 2020
NCT ID
NCT03703310About Patidegib Topical Gel, 2% + Patidegib Topical Gel, Vehicle
Patidegib Topical Gel, 2% + Patidegib Topical Gel, Vehicle is a phase 3 stage product being developed by Sol-Gel Technologies for Basal Cell Nevus Syndrome. The current trial status is completed. This product is registered under clinical trial identifier NCT03703310. Target conditions include Basal Cell Nevus Syndrome.
What happened to similar drugs?
1 of 6 similar drugs in Basal Cell Nevus Syndrome were approved
Approved (1) Terminated (2) Active (3)
Hype Score Breakdown
Clinical
17
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04155190 | Phase 2 | Terminated |
| NCT03703310 | Phase 3 | Completed |
Competing Products
20 competing products in Basal Cell Nevus Syndrome